KSBL is dedicated to lead the field of nano-medicine by continuously seeking ways for innovative research and development. Established in 2023, KSBL is a pharmaceutical company based in South Korea and a joint venture between SN BioScience and KUKJEON. Leveraging our expertise in oncological production, we strive to develop cutting-edge nano-carriers for precise delivery. Our product pipeline aims to include various generics of cytotoxic injection to treat variety of cancers. We are also committed to exporting our technologies to other countries, to ensure global access of our groundbreaking solutions
Company Details
- Founded
- -
- Address
- #a-2004 Geumgang Penterium It Tower, 282 Hagui-Ro, #a-2004,korea, Republic Of
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.ks-biologics.com
- HQ
- Dongan-gu, Anyang-si, Gyeonggi-do
Ks-Biologics Questions
Ks-Biologics's website is http://www.ks-biologics.com
Ks-Biologics's LinkedIn profile is https://kr.linkedin.com/company/ks-biologics
Ks-Biologics's industry is
Pharmaceutical Manufacturing
Ks-Biologics's top competitors are
Mia,
Edis Agency,
Promedius,
Datasphere Lab @ Mcgill University,
Escape Platforms,
Derucci International Holdings Ltd.,
Ai4good Lab,
Ourhealth,
Nuro Corp.,
Ksbiomed Healthcare Pvt. Ltd..
Ks-Biologics's categories are Pharmaceutical Manufacturing
Ks-Biologics's founding year is 2023
